A. Haraldsson et al., The additive pulmonary vasodilatory effects of inhaled prostacyclin and inhaled milrinone in postcardiac surgical patients with pulmonary hypertension, ANESTH ANAL, 93(6), 2001, pp. 1439-1445
Citations number
24
Categorie Soggetti
Aneshtesia & Intensive Care","Medical Research Diagnosis & Treatment
Selective pulmonary vasodilation is an advantageous therapeutic strategy fo
r cardiac surgical patients with increased pulmonary vascular resistance (P
VR) and right ventricular failure. We hypothesized that milrinone, an adeno
sine-3 ' ,5 ' -cyclic monophosphate (cAMP)-selective phosphodiesterase enzy
me (PDE) inhibitor may, when nebulized and inhaled, cause selective pulmona
ry vasodilation and potentiate the vasodilation by inhaled prostacyclin (iP
GI(2)). Consequently, we investigated the hemodynamic effects of inhaled mi
lrinone or the combination iPGI(2) + inhaled milrinone in cardiac surgical
patients (MPAP) > 25 mm. Hg and PVR > 200 dynes . s(-1). cm(-5). During mec
hanical ventilation and using a conventional nebulizing system, 9 patients
inhaled incremental concentrations of milrinone (0.25, 0.5 and 1 mg/mL) in
subsequent 10-min periods (Study Part 1). In the same manner, 11 patients r
eceived iPGI(2) (10 mug/mL) followed by the combination of iPGI(2) (10 mug/
mL) and inhaled milrinone (1 mg/mL) (Study Part 2). Inhaled milrinone reduc
ed PVR with a maximal effect (- 20%, P < 0.001) at the largest concentratio
n. As compared with iPGI(2) alone, iPGI(2) + inhaled milrinone caused a fur
ther and prolonged reduction of PVR (-8%, P < 0.05) and increased stroke vo
lume (+5%, P < 0.05). Systemic vascular resistance or mean arterial pressur
e was not affected by inhalation of either drug(s). The authors conclude th
at inhalation of the cAMP-selective PDE-inhibitor milrinone selectively dil
ates the pulmonary vasculature without systemic effects in cardiac surgical
patients with pulmonary hypertension. Furthermore, inhaled milrinone appea
rs to potentiate and prolong the pulmonary selective vasodilatory effect of
iPGI(2). Inhaled milrinone alone or combined with iPGI(2) may be an import
ant therapeutic option in the treatment of patients with pulmonary hyperten
sion and right ventricular failure.